Acumen Pharmaceuticals, Inc. (ABOS) Misses Q3 EPS by 14c

Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) reported Q3 EPS of ($0.50), $0.14 worse than the analyst estimate of ($0.36).

For earnings history and earnings-related data on Acumen Pharmaceuticals, Inc. (ABOS) click here.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• Stifel Starts Victrex Plc. (VCT:LN) (VTXPF) at Buy
• Carnival Corp. (CCL) call put ratio 1.2 calls to 1 put into quarter results